These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28775176)

  • 1. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chim CS
    J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact.
    Li Z; Wong KY; Calin GA; Chng WJ; Chan GC; Chim CS
    Clin Epigenetics; 2019 May; 11(1):71. PubMed ID: 31064412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
    Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
    Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression Analysis and Epigenetics of MicroRNA-28-5p in Multiple Myeloma].
    Gao YN; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1540-1547. PubMed ID: 31607309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.
    Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC
    Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the miR-124-1 in haematological malignancies.
    Wong KY; So CC; Loong F; Chung LP; Lam WW; Liang R; Li GK; Jin DY; Chim CS
    PLoS One; 2011 Apr; 6(4):e19027. PubMed ID: 21544199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent methylation of the tumour suppressor miR-1258 targeting PDL1: implication in multiple myeloma-specific cytotoxicity and prognostification.
    Wang LQ; Kumar S; Calin GA; Li Z; Chim CS
    Br J Haematol; 2020 Jul; 190(2):249-261. PubMed ID: 32079038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
    Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
    Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
    Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
    Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1250-5p is a novel tumor suppressive intronic miRNA hypermethylated in non-Hodgkin's lymphoma: novel targets with impact on ERK signaling and cell migration.
    Zhang MY; Wang LQ; Chim CS
    Cell Commun Signal; 2021 May; 19(1):62. PubMed ID: 34044822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
    Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
    Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells.
    Skårn M; Barøy T; Stratford EW; Myklebost O
    PLoS One; 2013; 8(11):e79231. PubMed ID: 24236112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma.
    Nojima M; Maruyama R; Yasui H; Suzuki H; Maruyama Y; Tarasawa I; Sasaki Y; Asaoku H; Sakai H; Hayashi T; Mori M; Imai K; Tokino T; Ishida T; Toyota M; Shinomura Y
    Clin Cancer Res; 2009 Jul; 15(13):4356-64. PubMed ID: 19549772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma.
    Qi J; Shi LY; Wu Y; Shen XJ; Yuan J; Jin CJ; Cong H; Ju SQ
    Leuk Lymphoma; 2019 Dec; 60(13):3188-3198. PubMed ID: 31190579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.